Clara cell protein (CC-16) and surfactant-associated protein A (SP-A) in asbestos-exposed workers

Chest

Volumn 109, Issue 2, 1996, Pages 467-474

  Lesur, Olivier ^a,c   Bernard, Alfred M ^b   Begin, Raymond O ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

Author keywords

asbestosis; epithelium; phospholipase A2; surfactant associated protein

Indexed keywords

ASBESTOS; PHOSPHOLIPASE A2; SURFACTANT ASSOCIATED PROTEIN;

ADULT; ARTICLE; ASBESTOSIS; CLARA CELL; CLINICAL ARTICLE; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HOST RESISTANCE; HUMAN; LUNG ALVEOLUS SURFACE TENSION; LUNG FIBROSIS; LUNG LAVAGE; MALE; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; PROTEIN DETERMINATION; SMOKING;

EID: 0030020962     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.109.2.467     Document Type: Article

References (42)

1. Crystal RG, Gadek JE, Ferrans VJ, et al. Interstitial lung disease: current concepts of pathogenesis, staging and therapy. Am J Med 1981; 70:542-68
2. Bégin R, Cantin A, Massé S. Recent advances in the pathogenesis and clinical assessment of mineral dust pneumoconioses: asbestosis, silicosis and coal pneumoconiosis. Eur Respir J 1989; 2:988-1001
3. Kawanami O, Ferrans VJ, Crystal RC. Structure of alveolar epithelial cells in patients with fibrotic lung disorders. Lab Invest 1982; 46:39-53
4. Fulmer JD, Roberts WC, von Gal ER, et al. Small airways in idiopathic pulmonary fibrosis. J Clin Invest 1977; 60:595-610
5. Wright JL, Churg A. Morphology of small-airway lesions in patients with asbestos exposure. Hum Pathol 1984; 15:68-74
6. Churg A, Wright JL. Small-airway lesions in patients exposed to nonasbestos mineral dusts. Hum Pathol 1983; 14:688-93
7. Brody AR, Overby LH. Incorporation of tritiated thymidine by epithelial and interstitial cells in bronchioloalveolar regions of asbestos-exposed rats. Am J Pathol 1989; 134:133-40
8. McGavran PD, Butterick CJ, Brody AR. Tritiated thymidine incorporation and the development of an interstitial lesion in the bronchioloalveolar regions of the lungs of normal and complement deficient mice after inhalation of chrysotile asbestos. J Environ Pathol Toxicol Oncol 1990; 9:377-92
9. Evans MJ, Cabral-Anderson LJ, Freeman G. Role of the Clara cell in renewal of the bronchiolar epithelium. Lab Invest 1978; 38:648-55
10. Massaro GD. The Clara cell: secretory and developmental studies in the rat. Eur J Respir Dis 1987; 71(suppl 153):52-8
11. Sallenave JM, Silva A, Marsden ME, et al. Secretion of mucous proteinase inhibitor and elafin by Clara cell and type II pneumocyte cell lines. Am J Respir Cell Mol Biol 1993; 8:126-33
12. Auten RL, Watkins RH, Shapiro DL, et al. Surfactant apoprotein A (SP-A) is synthesized in airway cells. Am J Respir Cell Mol Biol 1990; 3:491-96
13. Bernard A, Dumont X, Roels H, et al. The molecular mass and concentrations of protein 1 or Clara cell protein in biological fluids: a reappraisal. Clin Chim Acta 1993; 223:189-91
14. Bernard A, Marchandise FX, Depelchin S, et al. Clara cell protein in serum and bronchoalveolar lavage. Kur Respir J 1992; 5: 1231-38
15. Hagen G, Wolf M, Katyal SL, et al. Tissue-specific expression, hormonal regulation and 5′-flanking gene region of the rat Clara cell 10 kDa protein: comparison to rabbit uteroglobin. Nucleic Acid Res 1990; 18:2939-46
16. Bernard A, Roels H, Lauwerys R, et al. Human urinary protein 1: evidence lor identity with the Clara cell protein and occurrence in respiratory tract and urogenital secretions. Clin Chim Acta 1992; 207:239-49
17. Andersson O, Nordlung-Möller L, Brönnegard M, et al. Purification and level of expression in bronchoalveolar lavage of a human polychlorinated biphenyl (PCB)-binding protein: evidence for a structural and functional kinship to the multihormonally regulated protein uteroglobin. Am J Respir Cell Mol Biol 1991; 5:6-12
18. Singh G, Katyal SL, Brown WE, et al. Clara cell 10 kDa protein (CC-10): comparison of structure and function with uteroglobin. Biochim Biophys Acta 1990; 1039:348-55
19. 2-mediated inhibition of fibroblast migration in vitro. Am J Respir Crit Care Med 1995; 152:290-97
20. Miele L, Cordella-Miele E, Facchiano A, et al. Novel antiinflammatory peptides from the region of the highest similarity between uteroglobin and lipocortin I. Nature 1988; 335:726-30
21. Hawgood S, Clements JA. Pulmonary surfactant and its apoproteins. J Clin Invest 1990; 86:1-6
22. van Iwaarden F, Welmers B, Verhoef J, et al. Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages. Am J Respir Cell Mol Biol 1990; 2:91-8
23. Wright JR, Youmans DC. Pulmonary surfactant protein A stimulates chemotaxis of alveolar macrophage. Am J Physiol 1993; 264:L338-44
24. 2 by surfactant protein A. Am J Physiol 1994; 267:L335-41
25. Kawada H, Horiuchi T, Shannon JM, et al. Alveolar type II cells, surfactant protein A (SP-A), and the phospholipid components of surfactant in silicosis. Am Rev Respir Dis 1989; 140:460-70
26. Lesur O, Veldhuizen RAW, Whitsett JA, et al. Surfactant-associated proteins (SP-A, SP-B) are increased proportionally to alveolar phospholipids in sheep silicosis. Lung 1993; 171:63-74
27. Gregory TJ, Longmore WJ, Moxley MA, et al. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 1991; 88:1976-81
28. Baughman RP, Sternberg RI, Hull W, et al. Decreased surfactant protein A in patients with bacterial pneumonia. Am Rev Respir Dis 1993; 147:653-57
29. McCormack FX, King TE, Voelker DR, et al. Idiopathic pulmonary fibrosis: abnormalities in the bronchoalveolar lavage content of surfactant protein A. Am Rev Respir Dis 1991; 144:160-66
30. Bégin R, Cantin A, Berthianme Y, et al. Clinical features to stage the alveolitis in asbestos workers. Am J Ind Med 1985; 8:521-36
31. McMahan MJ, Mimouni F, Miodovnik M, et al. Surfactant-associated protein (SAP-35) in amniotic fluid from diabetic and nondiabetic pregnancies. Obstet Gynecol 1987; 70:94-8
32. Cherniak RM, Banks DE, Bell DY, et al. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis. and selected comparison groups. Am Rev Respir Dis 1990; 141(suppl, pt 2):S169-202
33. Rom WN, Travis WD, Brody AR. Cellular and molecular basis of the asbestos-related diseases. Am Rev Respir Dis 1991; 143:408-22
34. Bégin R, Rola-Pleszczynski M, Massé S, et al. Assessment of progression of asbestosis in the sheep model by bronchoalveolar lavage and pulmonary function tests. Thorax 1983; 38:449-57
35. Brody AR, Roe MW. Deposition pattern of inorganic particles at the alveolar level in the lungs of rats and mice. Am Rev Respir Dis 1983; 128:724-29
36. Batenburg JJ. Surfactant phospholipids: synthesis and storage. Am J Physiol 1992; 262:L367-85
37. Mantile C, Miele L, Cordella-Miele E, et al. Human Clara cell 10-kDa protein is the counterpart of rabbit uteroglobin. J Biol Chem 1993; 268:20343-51
38. 2 in the pathobiology of disease. Lab Invest 1986; 55:391-404
39. 2 and proteins. Environ Health Perspect 1983; 51:293-98
40. Schwartz, DA, Calvin JR, Merchant RK, et al. Influence of cigarette smoking on bronchoalveolar lavage cellularity in asbestos-induced lung disease. Am Rev Respir Dis 1992; 145:400-05
41. Schwartz DA, Heiniers RA, Dayton CS, et al. Determinants of bronchoalveolar lavage cellulariry in idiopathic pulmonary fibrosis. J Appl Physiol 1991; 71:1688-93
42. Lumsden AB, McLean A, Lamb D, Goblet and Clara cells of human distal airways: evidence for smoking induced changes in their numbers. Thorax 1984; 39:844-49